May 13, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
DESTIN, Fla. — New treatments have improved outcomes in lupus, but preventing disease in the early stages remains elusive, according to a speaker at the Congress of Clinical Rheumatology East.“We have seen amazing progress in lupus,” Judith A. James, MD, PhD, executive vice president and chief medical officer of the arthritis and clinical immunology research program at Oklahoma
May 13, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

CLEVELAND — For the first time in decades, targeted therapies to treat cutaneous lupus erythematosus are advancing through the…

DESTIN, Fla. — Most patients with systemic sclerosis require treatment with multiple modes of action, according to a presenter at…

Three dosing levels of enpatoran each reduced disease activity among patients with skin manifestations of cutaneous or systemic…

Find the latest Dermatology and Therapeutics news articles, videos, podcasts, and meeting coverage from medical experts and key…

Patients with systemic lupus erythematosus who received autologous chimeric antigen receptor T-cell therapy enjoyed potent B-cell…

For one of the two, the benefits continue long after treatment stops